Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Travere Therapeutics (TVTX) Is Up 14.0% After FDA Focus Shifts To FILSPARI FSGS Label Expansion - Has The Bull Case Changed?

Travere Therapeutics is drawing fresh attention after traders reacted to the upcoming April 13, 2026 FDA PDUFA decision on a supplemental filing for its rare kidney disease drug FILSPARI in focal segmental glomerulosclerosis, alongside a recent analyst upgrade to a Buy rating. This combination of a potential label expansion in an area with limited treatment options and an improved analyst stance is sharpening focus on how central FILSPARI has become to Travere’s rare disease strategy. We’ll...
SWX:IMPN
SWX:IMPNConstruction

Assessing Implenia (SWX:IMPN) Valuation After CHF 310 Million in New Climate Friendly Contracts

Implenia (SWX:IMPN) recently reported new building contracts in Switzerland and Germany worth more than CHF 310 million. These cover residential, commercial and institutional projects scheduled between 2026 and 2028, with a strong emphasis on timber and climate-friendly construction. See our latest analysis for Implenia. Despite the new CHF 310 million contract wins, Implenia’s share price has a 30 day share price return of 10.1% and a year to date share price return of 18%. At the same time,...
NYSE:SMA
NYSE:SMASpecialized REITs

Assessing SmartStop Self Storage REIT (SMA) Valuation As Narratives Flag Potential Undervaluation

Recent returns and business snapshot SmartStop Self Storage REIT (SMA) has traded around US$30.43 recently, with a 1 day total return near 0.5%. The stock shows negative returns over the past week, month, past 3 months and year. The company reports annual revenue of about US$267.83 million and a net loss of roughly US$9.39 million, with a value score of 4 and an indicated intrinsic discount figure of about 44%. SmartStop’s operations center on self storage. The company reports segment revenue...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

DraftKings (DKNG) Valuation Check After Washington D.C. Sports Betting Lawsuit Is Dismissed

DraftKings (DKNG) is back in focus after a federal judge dismissed a Washington D.C. lawsuit that challenged the legality of online sports betting, easing one regulatory overhang for operators in that market. See our latest analysis for DraftKings. Even with the legal win in Washington D.C., DraftKings’ share price has a 1-day share price return of 2.5% and 7-day share price return of 3.45%. This is set against a 30-day share price return of 6.97% and year-to-date share price return of...
SEHK:371
SEHK:371Water Utilities

Beijing Enterprises Water Group (SEHK:371) Valuation After 2025 Earnings Decline And Proposed Final Dividend

Beijing Enterprises Water Group (SEHK:371) has released full year 2025 results alongside a proposed final ordinary dividend of HK$0.0925 per share. This combination may influence how investors view this utility stock. See our latest analysis for Beijing Enterprises Water Group. The latest earnings and dividend news comes after a period where momentum has picked up, with a 90 day share price return of 13.01% and a 1 year total shareholder return of 24.43%, within a longer term 3 year total...
NasdaqGS:VFS
NasdaqGS:VFSAuto

Assessing VinFast Auto (NasdaqGS:VFS) Valuation After The VF 9 Electric SUV Launch

Why the VF 9 launch matters for VinFast Auto (NasdaqGS:VFS) investors VinFast Auto (NasdaqGS:VFS) is in focus after introducing the VF 9, a fully electric three row SUV aimed at families that want more space, comfort, and clearer long term ownership support. See our latest analysis for VinFast Auto. The VF 9 launch arrives alongside a sharp pickup in momentum, with a 7-day share price return of 32.69% and a 1-year total shareholder return of 28.93%, even as the 3-year total shareholder return...
NYSE:CPA
NYSE:CPAAirlines

A Look At Copa Holdings (NYSE:CPA) Valuation After Recent Share Price Volatility

Why Copa Holdings Is On Investors’ Radar Today Copa Holdings (NYSE:CPA) has been drawing attention after recent share price moves, with the stock up 3.8% over the past day but showing a 10.7% decline over the past month. See our latest analysis for Copa Holdings. The recent 1-day share price return of 3.79% and 7-day share price return of 2.28% come after a softer patch, with a 30-day share price return of negative 10.67%, while the 1-year total shareholder return of 37.80% points to...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Assessing Ichor Holdings (ICHR) Valuation After Analyst Upgrades And Signs Of Bullish Momentum

Recent analyst upgrades and renewed optimism around Ichor Holdings (ICHR) margins during a semiconductor upcycle have coincided with a 9.86% intraday rally, drawing attention to fresh technical signals and heavy options activity. See our latest analysis for Ichor Holdings. The latest 2.57% 1 day share price return takes Ichor Holdings to US$47.81. A 159.41% 90 day share price return and 134.25% year to date share price return contrast with a 111.46% 1 year total shareholder return, pointing...
NYSE:ARCO
NYSE:ARCOHospitality

Arcos Dorados 2026 Dividend Plan Sets Income Path Despite Valuation Tension

Arcos Dorados Holdings (NYSE:ARCO) has approved a cash dividend for 2026. The dividend is scheduled to be paid to shareholders in quarterly installments throughout 2026. The board decision sets out a defined timetable for cash returns to shareholders next year. Arcos Dorados, the largest independent McDonald’s franchisee in Latin America and the Caribbean, continues to operate in a consumer environment shaped by inflation pressures, shifting spending patterns and ongoing investment in...
TSE:5803
TSE:5803Electrical

Fujikura (TSE:5803) Valuation Check As AI Data Center Cabling Demand And Earnings Draw Closer

Event driven focus on Fujikura ahead of earnings Fujikura (TSE:5803) is back in the spotlight as investors react to its role in supplying high count optical cabling for AI data centers and look ahead to the May 12, 2026 earnings release. See our latest analysis for Fujikura. Recent trading has cooled after a strong run. The 7 day share price return is 7.66%, while the 30 day share price return reflects a 5.08% decline. However, a 90 day gain of 48.86% and a very large 1 year total shareholder...
NYSE:DV
NYSE:DVMedia

Assessing DoubleVerify (DV) Valuation After New Spectrum Reach Streaming Transparency Partnership

DoubleVerify Holdings (DV) is back in focus after announcing that Spectrum Reach will be the first participant in its Certified Transparent Streaming program, bringing program level transparency to streaming TV ad placements. See our latest analysis for DoubleVerify Holdings. The Spectrum Reach partnership arrives at a time when DoubleVerify’s 1 day share price return of 2.95% contrasts with a weaker 30 day share price return of 6.68% and a 1 year total shareholder return decline of 26.96%,...
ENXTAM:RAND
ENXTAM:RANDProfessional Services

A Look At Randstad (ENXTAM:RAND) Valuation As It Shifts From AEX To AMX Index

Index change puts Randstad (ENXTAM:RAND) under the spotlight Randstad (ENXTAM:RAND) is moving out of the large cap Amsterdam AEX Index and into the mid cap AMX Index, a shift that can reshape trading activity as index funds adjust their holdings. See our latest analysis for Randstad. At a share price of €22.6, Randstad’s 30 day share price return of 15.39% and year to date share price return of 30.25% come alongside a 1 year total shareholder return of 36.54%. Momentum appears to have faded...
HLSE:VAIAS
HLSE:VAIASElectronic

A Look At Vaisala Oyj’s (HLSE:VAIAS) Valuation After A Higher Dividend And Board Changes

Dividend decision and board changes at Vaisala Oyj Vaisala Oyj (HLSE:VAIAS) drew investor attention after its Annual General Meeting approved a dividend of €0.86 per share, along with several board and committee appointments that reshape its governance structure. See our latest analysis for Vaisala Oyj. The AGM news landed as the share price sits at €44.85, with a 30 day share price return of 6.07% decline but a 3 year total shareholder return of 23.62%, suggesting longer term holders have...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

MOMENTUM Data Expands Hypercortisolism Opportunity For Corcept Investors

Corcept Therapeutics (NasdaqCM:CORT) presented new late breaking MOMENTUM trial data at the American College of Cardiology 2026 Annual Scientific Session. The study reported a high prevalence of previously undiagnosed endogenous hypercortisolism in patients with resistant hypertension. The findings suggest a larger pool of patients who might be candidates for therapies that target hypercortisolism. For you as a shareholder or potential investor, this update adds an extra layer to the usual...
SEHK:1811
SEHK:1811Renewable Energy

Assessing CGN New Energy Holdings (SEHK:1811) Valuation After FY2025 Earnings And Dividend Announcement

CGN New Energy Holdings (SEHK:1811) recently reported full year 2025 earnings, with net income of US$275.87 million on sales of US$1,692.85 million, and announced an annual dividend of HK$0.1254 per share. See our latest analysis for CGN New Energy Holdings. The latest earnings release and higher annual dividend appear to have sharpened investor attention, with a 7.57% 1 day share price return helping extend the 8.43% 90 day share price return and 60.52% 5 year total shareholder return,...
NYSE:HLIO
NYSE:HLIOMachinery

How Earnings Beat, Jacuzzi Deal and Dividend Move Will Impact Helios Technologies (HLIO) Investors

Helios Technologies recently reported stronger-than-expected fourth-quarter 2025 non-GAAP earnings of US$0.81 per share with growth in both Electronics and Hydraulics segments, while also declaring a quarterly dividend of US$0.12 per share payable on April 27, 2026, to shareholders of record on April 13, 2026. Through its Balboa Water Group subsidiary, Helios is deepening its more-than-decade-long partnership with Jacuzzi Group by supplying advanced control, display, and multi-zone lighting...
WBAG:OMV
WBAG:OMVOil and Gas

A Look At OMV’s (WBAG:OMV) Valuation After Recent Share Price Strength

OMV share performance snapshot after recent moves OMV (WBAG:OMV) has attracted renewed attention after recent price moves, with the share closing at €61.60 and posting returns of 7.9% over the past month and 29.6% over the past 3 months. See our latest analysis for OMV. While the share price dipped 2.5% on the day to €61.60, the 30 day share price return of 7.9% and year to date gain of 27.6% suggest momentum has been building, supported by a 1 year total shareholder return of 43.2% and 3...
NYSE:AXP
NYSE:AXPConsumer Finance

A Look At American Express’s Valuation As New NFL Partnership Expands Sports And Entertainment Reach

American Express (AXP) is leaning further into sports and entertainment with a new multi year global partnership that will name the company the NFL’s Official Payments Partner starting in the 2026 season. See our latest analysis for American Express. The NFL partnership lands at a time when American Express shares trade at US$301.45, with recent share price returns weaker over the past quarter and year to date, while multi year total shareholder returns remain firmly positive. This suggests...
NasdaqCM:USAU
NasdaqCM:USAUMetals and Mining

U.S. Gold CK Project Study Highlights Cash Flow Potential And Funding Questions

U.S. Gold Corp. (NasdaqCM:USAU) released its Feasibility Study results for the fully permitted CK Gold Project in Wyoming. The study outlines project economics and highlights options such as mine expansion, longer mine life and additional revenue sources. The CK Gold Project is described as shovel ready, with all key permits in place. U.S. Gold, trading at $15.8, sits at a notable point in its development, with the CK Gold Project having cleared a major technical and regulatory hurdle. The...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After An 84% One Year Share Price Jump

If you are wondering whether Syndax Pharmaceuticals' current share price reflects its true worth, this article walks through the key valuation checks that can help you frame that question clearly. The stock recently closed at US$23.88, after a 7.9% gain over the past month, a 12.1% return year to date, and 84.1% over the last year. These moves may have changed how the market views both its potential and its risks. Recent coverage has focused on Syndax Pharmaceuticals in the context of its...
NYSE:MOS
NYSE:MOSChemicals

How Margin Pressure and Downgrades At Mosaic (MOS) Have Changed Its Investment Story

In recent weeks, Mosaic reported mixed earnings as higher potash and phosphate prices were offset by lower volumes and rising production costs, while phosphate markets were described as tight due to limited new supply. At the same time, UBS and Bank of America downgraded Mosaic, highlighting potash oversupply risks, pressure on phosphate margins from higher sulfur and ammonia costs, and progress on the company’s Brazilian rare-earths joint venture now moving into prefeasibility with...
SWX:AMRZ
SWX:AMRZBasic Materials

New Amrize CFO Baris Oran May Reframe Capital And M&A Priorities

Amrize (SWX:AMRZ) has appointed Baris Oran as Chief Financial Officer and member of the Executive Committee. The appointment is effective April 1 and represents a major change in the company’s top leadership team. Oran brings international financial leadership experience from prior CFO and executive roles at large multinational companies, including GXO Logistics. For investors watching Amrize (SWX:AMRZ), a change in the CFO seat can matter as much as product launches or new contracts. The...
BME:ALM
BME:ALMPharmaceuticals

Why Almirall (BME:ALM) Is Up 6.2% After Strong Four-Year Lebrikizumab Phase 3b Data

Almirall, S.A. recently reported positive long-term interim Phase 3b ADlong results for lebrikizumab in moderate-to-severe atopic dermatitis, showing sustained efficacy and a consistent safety profile over up to four years, at the American Academy of Dermatology meeting in Denver. The data, including high rates of near-complete skin clearance and itch relief mostly achieved without topical corticosteroids, underline lebrikizumab’s potential to anchor Almirall’s European dermatology franchise...
NYSE:MTN
NYSE:MTNHospitality

A Look At Vail Resorts (MTN) Valuation As New Antitrust Lawsuit Challenges Its Pricing Model

Antitrust lawsuit raises fresh questions for Vail Resorts stock A new federal antitrust class action against Vail Resorts (MTN) and Alterra Mountain Company is challenging how the two major operators price and bundle their ski passes across North America. The complaint, filed in the U.S. District Court for the District of Colorado, alleges that season pass bundles and single day lift-ticket pricing practices have restricted competition and pushed costs higher for skiers and snowboarders. See...